Allergy and Sensitivity Tests of Uncertain Efficacy
Customize your policy alerts
Sign up for all regence policy alerts
Know when regence releases new policies or updates existing guidance.
Monitor payer policy activity
This policy governs coverage of allergy and sensitivity tests considered investigational because scientific evidence does not permit conclusions regarding their effects on health outcomes. It addresses tests of uncertain efficacy or primarily used in research settings and does not address allergy tests considered clinically useful.
No material clinical or coverage changes in this revision.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.